Hale Gök Dağıdır
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hale Gök Dağıdır has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ayşen Çalıkuşu
Department of Neuroscience, Institute of Health Sciences Gazi University Ankara Türkiye
6 shared publications - Meltem Bahcelioglu
Department of Anatomy Faculty of Medicine, Neuroscience and Neurotechnology Center of Excellence (NÖROM), Neuropsychiatry Education, Research and Application Center Gazi University Ankara Türkiye
6 shared publications - Neslihan Bukan
Department of Medical Biochemistry Faculty of Medicine Gazi University Ankara Türkiye
6 shared publications - Ece Alim
Neuroscience and Neurotechnology Center of Excellence (NÖROM) Gazi University Ankara Türkiye
5 shared publications - Elif Gulcicek Abbasoglu Topa
Neuropsychiatry Education, Research and Application Center (NPM) Gazi University Ankara Türkiye
4 shared publications - Hayrunnisa Bolay
Neuroscience and Neurotechnology Center of Excellence (NÖROM), Gazi University, Ankara, Turkiye
4 shared publications
Latest Publications
- Open Access
- 8 June 2026
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (6) , e70633
tVNS Mitigates Neuroinflammation and Nociception in a Rodent LPS Endotoxemia Model
The vagus nerve plays a modulatory role in the gut‐brain axis. Intestinal barrier dysfunction and lipopolysaccharide (LPS) leakage into the systemic circulation are associated with several conditions, such as irritable bowel syndrome (IBS) and migraine headache. This study investigates the impact of non‐invasive transauricular vagus nerve stimulation (tVNS) on the neuroinflammatory markers and pain behavior following an acute LPS challenge. Sprague–Dawley rats ( n = 28) were given LPS or vehicle and subjected to tVNS or sham intervention in an acute LPS animal model that mimics the systemic consequences of barrier dysfunction. Behaviors were evaluated at the baseline and 6 h later, complemented by testing the levels of serum and brain neuroinflammatory markers. Behavioral analyses revealed that LPS exposure reduced the time spent in the open arm, grooming duration, and periorbital mechanical pain thresholds, and increased freezing duration. The tVNS intervention reversed these behavioral changes induced by LPS. LPS administration triggered elevated serum levels of IL‐6, CGRP, haptoglobin, and VE‐cadherin. LPS also increased IL‐1β, PAR‐2, haptoglobin, CGRP, and HMGB1 levels in the brain tissue. The tVNS intervention reversed the effects observed in the brain, but it did not change the elevated levels of inflammatory molecules in the systemic circulation. tVNS has the potential to modulate neuroimmune interactions, with an early impact on the brain during LPS surge. tVNS may have potential therapeutic benefits in managing pain‐related disorders associated with LPS endotoxemia.
- 8 June 2026
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (6) , e70633
Open AccesstVNS Mitigates Neuroinflammation and Nociception in a Rodent LPS Endotoxemia Model
The vagus nerve plays a modulatory role in the gut‐brain axis. Intestinal barrier dysfunction and lipopolysaccharide (LPS) leakage into the systemic circulation are associated with several conditions, such as irritable bowel syndrome (IBS) and migraine headache. This study investigates the impact of non‐invasive transauricular vagus nerve stimulation (tVNS) on the neuroinflammatory markers and pain behavior following an acute LPS challenge. Sprague–Dawley rats ( n = 28) were given LPS or vehicle and subjected to tVNS or sham intervention in an acute LPS animal model that mimics the systemic consequences of barrier dysfunction. Behaviors were evaluated at the baseline and 6 h later, complemented by testing the levels of serum and brain neuroinflammatory markers. Behavioral analyses revealed that LPS exposure reduced the time spent in the open arm, grooming duration, and periorbital mechanical pain thresholds, and increased freezing duration. The tVNS intervention reversed these behavioral changes induced by LPS. LPS administration triggered elevated serum levels of IL‐6, CGRP, haptoglobin, and VE‐cadherin. LPS also increased IL‐1β, PAR‐2, haptoglobin, CGRP, and HMGB1 levels in the brain tissue. The tVNS intervention reversed the effects observed in the brain, but it did not change the elevated levels of inflammatory molecules in the systemic circulation. tVNS has the potential to modulate neuroimmune interactions, with an early impact on the brain during LPS surge. tVNS may have potential therapeutic benefits in managing pain‐related disorders associated with LPS endotoxemia.
- 21 November 2025
- Published by Wiley in Developmental Neurobiology
- Vol. 86 (1) , e23019
Targeting Brain Plasticity: Vagal Nerve Stimulation as a Therapy for Autism‐Like Symptoms in a Valproic Acid Mouse Model
Autism spectrum disorder (ASD) is a multifactorial neurodevelopmental condition defined by social deficits, stereotypical or repetitive behaviors, and anxiety. This study evaluates the therapeutic potential of transauricular vagal nerve stimulation (tVNS) in a valproic acid (VPA)‐induced mouse model of ASD. The study comprised three groups: the control + sham (saline‐treated offsprings receiving sham stimulation), the autistic + sham (VPA‐treated offspring receiving sham stimulation), and the autistic + tVNS (VPA‐treated offsprings receiving tVNS). Male C57BL/6 mice exposed to VPA on embryonic day 12.5 were evaluated for behavioral and neurobiological alterations. tVNS was applied twice weekly for 3 weeks to investigate its effects on sociability, anxiety‐like behaviors, neurogenesis markers, and apoptosis pathways. Behavioral testing, including the three‐chamber test, mirrored chamber test, open field test, and elevated plus maze, revealed that tVNS significantly improved sociability and social preference indices, reduced social anxiety, and decreased general anxiety‐like behaviors in VPA‐induced mice. Histological and immunohistochemical analyses have shown a decrease in neuron density, brain‐derived neurotrophic factor (BDNF), and doublecortin (DCX) expression in the hippocampus, amygdala, and prefrontal cortex of VPA‐induced mice. Additionally, the increase in caspase‐3 immunoreactivity indicates increased apoptosis. tVNS treatment restored BDNF and DCX levels, promoting neurogenesis and synaptic plasticity while significantly reducing caspase‐3‐mediated apoptosis in affected brain regions. These findings suggest that tVNS may counteract the neural and behavioral deficits associated with ASD by modulating neurogenesis, neuronal plasticity, and apoptosis. The study highlights tVNS as a potential therapeutic intervention for ASD, emphasizing its role in targeting both behavioral alterations and underlying neurobiological mechanisms.
- 21 November 2025
- Published by Wiley in Developmental Neurobiology
- Vol. 86 (1) , e23019
Targeting Brain Plasticity: Vagal Nerve Stimulation as a Therapy for Autism‐Like Symptoms in a Valproic Acid Mouse Model
Autism spectrum disorder (ASD) is a multifactorial neurodevelopmental condition defined by social deficits, stereotypical or repetitive behaviors, and anxiety. This study evaluates the therapeutic potential of transauricular vagal nerve stimulation (tVNS) in a valproic acid (VPA)‐induced mouse model of ASD. The study comprised three groups: the control + sham (saline‐treated offsprings receiving sham stimulation), the autistic + sham (VPA‐treated offspring receiving sham stimulation), and the autistic + tVNS (VPA‐treated offsprings receiving tVNS). Male C57BL/6 mice exposed to VPA on embryonic day 12.5 were evaluated for behavioral and neurobiological alterations. tVNS was applied twice weekly for 3 weeks to investigate its effects on sociability, anxiety‐like behaviors, neurogenesis markers, and apoptosis pathways. Behavioral testing, including the three‐chamber test, mirrored chamber test, open field test, and elevated plus maze, revealed that tVNS significantly improved sociability and social preference indices, reduced social anxiety, and decreased general anxiety‐like behaviors in VPA‐induced mice. Histological and immunohistochemical analyses have shown a decrease in neuron density, brain‐derived neurotrophic factor (BDNF), and doublecortin (DCX) expression in the hippocampus, amygdala, and prefrontal cortex of VPA‐induced mice. Additionally, the increase in caspase‐3 immunoreactivity indicates increased apoptosis. tVNS treatment restored BDNF and DCX levels, promoting neurogenesis and synaptic plasticity while significantly reducing caspase‐3‐mediated apoptosis in affected brain regions. These findings suggest that tVNS may counteract the neural and behavioral deficits associated with ASD by modulating neurogenesis, neuronal plasticity, and apoptosis. The study highlights tVNS as a potential therapeutic intervention for ASD, emphasizing its role in targeting both behavioral alterations and underlying neurobiological mechanisms.
- Open Access
- 14 October 2024
- Published by Wiley in FEBS Open Bio
- Vol. 15 (1) , 69-80
tVNS alters inflammatory response in adult VPA‐induced mouse model of autism: evidence for sexual dimorphism
Autism is a neurodevelopmental disorder with limited treatment alternatives and which incidence is increasing. Some research suggests that vagus nerve simulation might lead to the reduction of certain symptom. Therefore, we aimed to examine the effect of bilateral transcutaneous auricular vagus nerve stimulation (tVNS) on the inflammatory response in an adult valproic acid (VPA) induced mouse (C57BL6) model of autism for the first time. The autism model was induced by oral VPA administration (600 mg·kg−1) to C57BL/6 pregnant mice on E12.5 days. The study included three groups: the VPA Transcutaneous Auricular Stimulation Group (VPA + tVNS), the VPA Control Group (VPA + sham), and the Healthy Control Group (Control + sham). Each group included 16 mice (8 M/8 F). Our results show that serum IL‐1β and IL‐6 levels were significantly higher in male VPA‐exposed mice than controls. However, IL‐1β was significantly lower, and IL‐6, TNF‐ α, and IL‐22 were not different in female VPA‐exposed mice compared to the control group. Brain NLRP3 levels were significantly higher in both sexes in the VPA autism model (P < 0.05). tVNS application increased brain NLRP3 levels in both sexes and reduced serum IL‐1β levels in male mice. We conclude that cytokine dysregulation is associated with the VPA‐induced adult autism model, and the inflammatory response is more pronounced in male mice. tVNS application altered the inflammatory response and increased brain NLPR3 levels in both sexes. Further studies are needed to understand the beneficial or detrimental role of the inflammatory response in autism and its sexual dimorphism.
- 14 October 2024
- Published by Wiley in FEBS Open Bio
- Vol. 15 (1) , 69-80
Open AccesstVNS alters inflammatory response in adult VPA‐induced mouse model of autism: evidence for sexual dimorphism
Autism is a neurodevelopmental disorder with limited treatment alternatives and which incidence is increasing. Some research suggests that vagus nerve simulation might lead to the reduction of certain symptom. Therefore, we aimed to examine the effect of bilateral transcutaneous auricular vagus nerve stimulation (tVNS) on the inflammatory response in an adult valproic acid (VPA) induced mouse (C57BL6) model of autism for the first time. The autism model was induced by oral VPA administration (600 mg·kg−1) to C57BL/6 pregnant mice on E12.5 days. The study included three groups: the VPA Transcutaneous Auricular Stimulation Group (VPA + tVNS), the VPA Control Group (VPA + sham), and the Healthy Control Group (Control + sham). Each group included 16 mice (8 M/8 F). Our results show that serum IL‐1β and IL‐6 levels were significantly higher in male VPA‐exposed mice than controls. However, IL‐1β was significantly lower, and IL‐6, TNF‐ α, and IL‐22 were not different in female VPA‐exposed mice compared to the control group. Brain NLRP3 levels were significantly higher in both sexes in the VPA autism model (P < 0.05). tVNS application increased brain NLRP3 levels in both sexes and reduced serum IL‐1β levels in male mice. We conclude that cytokine dysregulation is associated with the VPA‐induced adult autism model, and the inflammatory response is more pronounced in male mice. tVNS application altered the inflammatory response and increased brain NLPR3 levels in both sexes. Further studies are needed to understand the beneficial or detrimental role of the inflammatory response in autism and its sexual dimorphism.
- 1 January 2024
- Published by Yuksek Ihtisas Universitesi Saglik Bilimleri Dergisi, Yuksek Ihtisas Universitesi in Yüksek İhtisas Üniversitesi Sağlık Bilimleri Dergisi
- p. 66-72
Brain-Gut Network in Inflammatory Bowel Diseases and the Role of Vagal Nerve in Neuroinflammation
In both normal and pathological situations, the brain and gut communicate. Intestinal inflammation is crucial in the progression of systemic inflammation and neuroinflammation. Inflammatory Bowel Diseases, neurodegeneration, and neuroinflammation all benefit from elucidating the molecular relationships between the gut and the brain. Crohn’s disease, ulcerative colitis, and indeterminate colitis are chronic disorders characterized by recurring episodes of gastrointestinal inflammation. Inflammatory bowel disease has evolved into a global disease in the 21st century, affecting around 6.8 million individuals and increasing in prevalence. According to growing evidence using clinical, epidemiological, and experimental data, Inflammatory Bowel Disease predisposes people to central nervous system disorders. The goal of this review is to address current knowledge in inflammatory bowel disorders, to analyze the interconnections between Inflammatory Bowel Diseases and neurodegenerative and neuroinflammatory diseases all along the gut-brain axis, and to emphasize the role of neuroinflammation in Inflammatory Bowel Diseases. Finally, we address vagal nerve stimulation as a potential treatment because it is a critical component of brain-gut interactions and exerts a dual antiinflammatory role via its afferent and efferent fibers. Keywords: Inflammatory bowel diseases, brain-gut axis, microbiota, neuroinflammation, neurodegeneration, vagal nerve stimulation
- 1 January 2024
- Published by Yuksek Ihtisas Universitesi Saglik Bilimleri Dergisi, Yuksek Ihtisas Universitesi in Yüksek İhtisas Üniversitesi Sağlık Bilimleri Dergisi
- p. 66-72
Brain-Gut Network in Inflammatory Bowel Diseases and the Role of Vagal Nerve in Neuroinflammation
In both normal and pathological situations, the brain and gut communicate. Intestinal inflammation is crucial in the progression of systemic inflammation and neuroinflammation. Inflammatory Bowel Diseases, neurodegeneration, and neuroinflammation all benefit from elucidating the molecular relationships between the gut and the brain. Crohn’s disease, ulcerative colitis, and indeterminate colitis are chronic disorders characterized by recurring episodes of gastrointestinal inflammation. Inflammatory bowel disease has evolved into a global disease in the 21st century, affecting around 6.8 million individuals and increasing in prevalence. According to growing evidence using clinical, epidemiological, and experimental data, Inflammatory Bowel Disease predisposes people to central nervous system disorders. The goal of this review is to address current knowledge in inflammatory bowel disorders, to analyze the interconnections between Inflammatory Bowel Diseases and neurodegenerative and neuroinflammatory diseases all along the gut-brain axis, and to emphasize the role of neuroinflammation in Inflammatory Bowel Diseases. Finally, we address vagal nerve stimulation as a potential treatment because it is a critical component of brain-gut interactions and exerts a dual antiinflammatory role via its afferent and efferent fibers. Keywords: Inflammatory bowel diseases, brain-gut axis, microbiota, neuroinflammation, neurodegeneration, vagal nerve stimulation
- Open Access
- 1 January 2024
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 54 (1) , 33-41
Leaky gut and inflammatory biomarkers in a medication overuse headache model in male rats
Medication overuse is common among chronic migraine patients and nonsteroidal antiinflammatory drugs (NSAIDs)are the most frequently overused drugs. The pathophysiological mechanisms underlying medication overuse headache (MOH) are notcompletely understood. Intestinal hyperpermeability and leaky gut are reported in patients using NSAIDs. The aim of the study is toinvestigate the role of leaky gut and inflammation in an MOH model MOH model in male rats.Methods: The study was conducted in male Sprague Dawley rats. There were two experimental groups. The first group was the chronicNSAID group in which the rats received mefenamic acid (n = 8) for four weeks intraperitoneally (ip) and the second group was thevehicle group (n = 8) that received 5% dimethyl sulfoxide+sesame oil (ip) for 4 weeks. We assessed spontaneous pain-like behavior,periorbital mechanical withdrawal thresholds, and anxiety-like behavior using an elevated plus maze test. After behavioral testing,serum levels of occludin and lipopolysaccharide-binding protein (LBP) and brain levels of IL-17, IL-6, and high mobility group box 1protein (HMGB1) were evaluated with ELISA.Results: Serum LBP and occludin levels and brain IL-17 and HMGB1 levels were significantly elevated in the chronic NSAID groupcompared to its vehicle (p = 0.006, p = 0.016, p = 0.016 and p = 0.016 respectively) while brain IL-6 levels were comparable (p = 0.67)between the groups. The chronic NSAID group showed pain-like and anxiety-like behavior in behavioral tests. Brain IL-17 level waspositively correlated with number of head shakes (r = 0.64, p = 0.045), brain IL-6 level was negatively correlated with periorbitalmechanical withdrawal thresholds (r = –0.71, p = 0.049), and serum occludin level was positively correlated with grooming duration (r= 0.73, p = 0.032) in chronic NSAID group.Conclusion: Elevated serum occludin and LBP levels and brain IL-17 and HMGB1 levels indicate a possible role of leaky gut andinflammation in an MOH model in male rats. Additionally, a significant correlation between pain behavior and markers of inflammationand intestinal hyperpermeability, supports the role of inflammation and leaky gut in MOH pathophysiology.
- 1 January 2024
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 54 (1) , 33-41
Open AccessLeaky gut and inflammatory biomarkers in a medication overuse headache model in male rats
Medication overuse is common among chronic migraine patients and nonsteroidal antiinflammatory drugs (NSAIDs)are the most frequently overused drugs. The pathophysiological mechanisms underlying medication overuse headache (MOH) are notcompletely understood. Intestinal hyperpermeability and leaky gut are reported in patients using NSAIDs. The aim of the study is toinvestigate the role of leaky gut and inflammation in an MOH model MOH model in male rats.Methods: The study was conducted in male Sprague Dawley rats. There were two experimental groups. The first group was the chronicNSAID group in which the rats received mefenamic acid (n = 8) for four weeks intraperitoneally (ip) and the second group was thevehicle group (n = 8) that received 5% dimethyl sulfoxide+sesame oil (ip) for 4 weeks. We assessed spontaneous pain-like behavior,periorbital mechanical withdrawal thresholds, and anxiety-like behavior using an elevated plus maze test. After behavioral testing,serum levels of occludin and lipopolysaccharide-binding protein (LBP) and brain levels of IL-17, IL-6, and high mobility group box 1protein (HMGB1) were evaluated with ELISA.Results: Serum LBP and occludin levels and brain IL-17 and HMGB1 levels were significantly elevated in the chronic NSAID groupcompared to its vehicle (p = 0.006, p = 0.016, p = 0.016 and p = 0.016 respectively) while brain IL-6 levels were comparable (p = 0.67)between the groups. The chronic NSAID group showed pain-like and anxiety-like behavior in behavioral tests. Brain IL-17 level waspositively correlated with number of head shakes (r = 0.64, p = 0.045), brain IL-6 level was negatively correlated with periorbitalmechanical withdrawal thresholds (r = –0.71, p = 0.049), and serum occludin level was positively correlated with grooming duration (r= 0.73, p = 0.032) in chronic NSAID group.Conclusion: Elevated serum occludin and LBP levels and brain IL-17 and HMGB1 levels indicate a possible role of leaky gut andinflammation in an MOH model in male rats. Additionally, a significant correlation between pain behavior and markers of inflammationand intestinal hyperpermeability, supports the role of inflammation and leaky gut in MOH pathophysiology.
- Open Access
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S570
TRANSAURICULAR VAGAL NERVE STIMULATION EFFECTS ON PRO- AND ANTI-INFLAMMATORY CYTOKINES IN AN EXPERIMENTAL MODEL OF AUTISTIC MICE
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S570
Open AccessTRANSAURICULAR VAGAL NERVE STIMULATION EFFECTS ON PRO- AND ANTI-INFLAMMATORY CYTOKINES IN AN EXPERIMENTAL MODEL OF AUTISTIC MICE
- Open Access
- 4 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S362
THE EFFECTS OF BILATERAL TRANSAURICULAR VAGUS NERVE STIMULATION ON LPS-INDUCED ACUTE INFLAMMATION AND PAIN BEHAVIOR
- 4 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S362
Open AccessTHE EFFECTS OF BILATERAL TRANSAURICULAR VAGUS NERVE STIMULATION ON LPS-INDUCED ACUTE INFLAMMATION AND PAIN BEHAVIOR